NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B
Estimated value
£192.0m
Awarded value
£192.0m
Awarded 15 Feb 2019
Suppliers
1
Lots
1
1 awarded
Published
25 Mar 2019
Deadline 11 Dec 2018
Awarded suppliers· 1 supplier
Awarded 15 Feb 2019 · Contract period 01 Mar 2019 — 28 Feb 2021
Award value
£192.0m